Cargando…
Breakthrough infection after three doses of COVID-19 mRNA vaccine in systemic autoimmune rheumatic diseases: two cases in patients on TNF inhibitor monotherapy
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8811273/ https://www.ncbi.nlm.nih.gov/pubmed/35110366 http://dx.doi.org/10.1136/rmdopen-2021-002082 |
_version_ | 1784644394946658304 |
---|---|
author | Vanni, Kathleen MM Patel, Naomi J DiIorio, Michael Kowalski, Emily Qian, Grace Cook, Claire E Ritter, Susan Y Wallace, Zachary S Sparks, Jeffrey A |
author_facet | Vanni, Kathleen MM Patel, Naomi J DiIorio, Michael Kowalski, Emily Qian, Grace Cook, Claire E Ritter, Susan Y Wallace, Zachary S Sparks, Jeffrey A |
author_sort | Vanni, Kathleen MM |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-8811273 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-88112732022-02-03 Breakthrough infection after three doses of COVID-19 mRNA vaccine in systemic autoimmune rheumatic diseases: two cases in patients on TNF inhibitor monotherapy Vanni, Kathleen MM Patel, Naomi J DiIorio, Michael Kowalski, Emily Qian, Grace Cook, Claire E Ritter, Susan Y Wallace, Zachary S Sparks, Jeffrey A RMD Open Infections BMJ Publishing Group 2022-02-02 /pmc/articles/PMC8811273/ /pubmed/35110366 http://dx.doi.org/10.1136/rmdopen-2021-002082 Text en © Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) . |
spellingShingle | Infections Vanni, Kathleen MM Patel, Naomi J DiIorio, Michael Kowalski, Emily Qian, Grace Cook, Claire E Ritter, Susan Y Wallace, Zachary S Sparks, Jeffrey A Breakthrough infection after three doses of COVID-19 mRNA vaccine in systemic autoimmune rheumatic diseases: two cases in patients on TNF inhibitor monotherapy |
title | Breakthrough infection after three doses of COVID-19 mRNA vaccine in systemic autoimmune rheumatic diseases: two cases in patients on TNF inhibitor monotherapy |
title_full | Breakthrough infection after three doses of COVID-19 mRNA vaccine in systemic autoimmune rheumatic diseases: two cases in patients on TNF inhibitor monotherapy |
title_fullStr | Breakthrough infection after three doses of COVID-19 mRNA vaccine in systemic autoimmune rheumatic diseases: two cases in patients on TNF inhibitor monotherapy |
title_full_unstemmed | Breakthrough infection after three doses of COVID-19 mRNA vaccine in systemic autoimmune rheumatic diseases: two cases in patients on TNF inhibitor monotherapy |
title_short | Breakthrough infection after three doses of COVID-19 mRNA vaccine in systemic autoimmune rheumatic diseases: two cases in patients on TNF inhibitor monotherapy |
title_sort | breakthrough infection after three doses of covid-19 mrna vaccine in systemic autoimmune rheumatic diseases: two cases in patients on tnf inhibitor monotherapy |
topic | Infections |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8811273/ https://www.ncbi.nlm.nih.gov/pubmed/35110366 http://dx.doi.org/10.1136/rmdopen-2021-002082 |
work_keys_str_mv | AT vannikathleenmm breakthroughinfectionafterthreedosesofcovid19mrnavaccineinsystemicautoimmunerheumaticdiseasestwocasesinpatientsontnfinhibitormonotherapy AT patelnaomij breakthroughinfectionafterthreedosesofcovid19mrnavaccineinsystemicautoimmunerheumaticdiseasestwocasesinpatientsontnfinhibitormonotherapy AT diioriomichael breakthroughinfectionafterthreedosesofcovid19mrnavaccineinsystemicautoimmunerheumaticdiseasestwocasesinpatientsontnfinhibitormonotherapy AT kowalskiemily breakthroughinfectionafterthreedosesofcovid19mrnavaccineinsystemicautoimmunerheumaticdiseasestwocasesinpatientsontnfinhibitormonotherapy AT qiangrace breakthroughinfectionafterthreedosesofcovid19mrnavaccineinsystemicautoimmunerheumaticdiseasestwocasesinpatientsontnfinhibitormonotherapy AT cookclairee breakthroughinfectionafterthreedosesofcovid19mrnavaccineinsystemicautoimmunerheumaticdiseasestwocasesinpatientsontnfinhibitormonotherapy AT rittersusany breakthroughinfectionafterthreedosesofcovid19mrnavaccineinsystemicautoimmunerheumaticdiseasestwocasesinpatientsontnfinhibitormonotherapy AT wallacezacharys breakthroughinfectionafterthreedosesofcovid19mrnavaccineinsystemicautoimmunerheumaticdiseasestwocasesinpatientsontnfinhibitormonotherapy AT sparksjeffreya breakthroughinfectionafterthreedosesofcovid19mrnavaccineinsystemicautoimmunerheumaticdiseasestwocasesinpatientsontnfinhibitormonotherapy |